생물학적 안전성 시험 제품 및 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biological safety testing products and services market size is expected to reach USD 15.89 Billion in 2034 from USD 6.23 Billion in 2025, growing at a CAGR of 10.97% during 2026-2034.The global biological safety testing products and services market is experiencing significant growth due to the rising demand for safe biopharmaceutical products and vaccines. Regulatory authorities require strict safety testing for biologics, including vaccines, cell therapies, and monoclonal antibodies, which is driving the adoption of advanced testing services and products. Increasing research activities in biotechnology and the expansion of pharmaceutical manufacturing facilities are further supporting market expansion.

The market is also benefiting from the growing pipeline of biologics and biosimilars worldwide. As the number of biologic drugs entering clinical trials increases, the need for contamination testing, endotoxin testing, and sterility testing is rising. Technological advancements in rapid microbiological methods and automated testing solutions are improving testing accuracy and efficiency. Pharmaceutical and biotechnology companies are increasingly adopting innovative testing platforms to ensure product quality and regulatory compliance.

Looking ahead, the market is expected to witness robust growth as biologics and advanced therapies continue to dominate the pharmaceutical landscape. The expansion of contract research organizations and testing laboratories will further boost outsourcing trends. Moreover, emerging markets are investing heavily in pharmaceutical manufacturing infrastructure, creating new opportunities for biological safety testing services. Continuous innovation in testing technologies and stringent regulatory standards will remain key factors shaping future growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Reagents & Kits
• Instruments
• Services

By Application

• Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein)
• Blood & Blood-Based Products
• Gene Therapy
• Tissue & Tissue-Based Products
• Stem Cell

By Test Type

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication & Characterization Tests
• Bioburden Tests
• Adventitious Agent Detection Tests
• Residual Host Contamination Detection Tests
• Others

COMPANIES PROFILED

• Charles River Laboratories, Eurofins Scientific, SGS, Labcorp, Thermo Fisher Scientific, Merck KGaA, Sartorius, Lonza, WuXi AppTec, Nelson Labs, Microbac Laboratories, BioReliance, Catalent, Intertek, Pace Analytical Services, Toxikon, Creative BioLabs, NAMSA, Q Laboratories, WuXi AppTec Testing

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood & Blood-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tissue & Tissue-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Endotoxin Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sterility Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cell Line Authentication & Characterization Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bioburden Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Adventitious Agent Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Residual Host Contamination Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By Test Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By Test Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By Test Type
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By Test Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By Test Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories
  • 9.2.2 Eurofins Scientific
  • 9.2.3 SGS
  • 9.2.4 Labcorp
  • 9.2.5 Thermo Fisher Scientific
  • 9.2.6 Merck KGaA
  • 9.2.7 Sartorius
  • 9.2.8 Lonza
  • 9.2.9 WuXi AppTec
  • 9.2.10 Nelson Labs
  • 9.2.11 Microbac Laboratories
  • 9.2.12 BioReliance
  • 9.2.13 Catalent
  • 9.2.14 Intertek
  • 9.2.15 Pace Analytical Services
  • 9.2.16 Toxikon
  • 9.2.17 Creative BioLabs
  • 9.2.18 NAMSA
  • 9.2.19 Q Laboratories
  • 9.2.20 WuXi AppTec Testing